Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Abstract CT010: A phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer (KGOG 3046/TRU-D)

Junsik Park, Eunhyang Park, Je-Gun Joung, Myong Cheol Lim, Byoung-Gie Kim, Jae Weon Kim, Jung Bok Lee, Sunghoon Kim, Chel Hun Choi, Hee Seung Kim, Sang Yoon Park, Jongsuk Chung, Jung-Yun Lee

Cancer Res (2022) 82 (12_Supplement): CT010.

DOI: https://doi.org/10.1158/1538-7445.AM2022-CT010

Published: 15 June 2022

View article

Journal Articles

Abstract CT123: Phase I study of a B cell-based and monocyte-based immunotherapeutic vaccine, BVAC-C, in human papillomavirus type 16- or 18-positive recurrent cervical cancer

Chel Hun Choi, Hyun Jin Choi, Jeong-Won Lee, Eun-Suk Kang, Duck Cho, Byung Kwan Park, Yong-Man Kim, Dae-Yeon Kim, Hyungseok Seo, Myunghwan Park, Wuhyun Kim, Ki-Young Choi, Taegwon Oh, Chang-Yuil Kang, Byoung-Gie Kim

Cancer Res (2020) 80 (16_Supplement): CT123.

DOI: https://doi.org/10.1158/1538-7445.AM2020-CT123

Published: 15 August 2020

View article

Journal Articles

Correction: Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF

Su Yeon Han, Aram Ko, Haruhisa Kitano, Chel Hun Choi, Min-Sik Lee, Jinho Seo, Junya Fukuoka, Soo-Youl Kim, Stephen M. Hewitt, Joon-Yong Chung, Jaewhan Song

Cancer Res (2018) 78 (24): 6903.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-3311

Published: 13 December 2018

View article

Journal Articles

Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3–NANOG Axis

Se Jin Oh, Hanbyoul Cho, Suhyun Kim, Kyung Hee Noh, Kwon-Ho Song, Hyo-Jung Lee, Seon Rang Woo, Suyeon Kim, Chel Hun Choi, Joon-Yong Chung, Stephen M. Hewitt, Jae-Hoon Kim, Seungki Baek, Kyung-Mi Lee, Cassian Yee, Hae-Chul Park, Tae Woo Kim

Cancer Res (2018) 78 (10): 2638–2653.

DOI: https://doi.org/10.1158/0008-5472.CAN-17-2325

Published: 14 May 2018

View article

Includes: Supplementary data

Journal Articles

HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells

Kwon-Ho Song, Chel Hun Choi, Hyo-Jung Lee, Se Jin Oh, Seon Rang Woo, Soon-Oh Hong, Kyung Hee Noh, Hanbyoul Cho, Eun Joo Chung, Jae-Hoon Kim, Joon-Yong Chung, Stephen M. Hewitt, Seungki Baek, Kyung-Mi Lee, Cassian Yee, Minjoo Son, Chih-Ping Mao, T.C. Wu, Tae Woo Kim

Cancer Res (2017) 77 (18): 5039–5053.

DOI: https://doi.org/10.1158/0008-5472.CAN-17-0072

Published: 14 September 2017

View article

Includes: Supplementary data

Journal Articles

Abstract 4718: Filamin A interacting protein 1-like is a marker of prognosis, progression and chemosensitivity in ovarian cancer

Mijung Kwon, Jae-Hoon Kim, Chel Hun Choi, Joon-Yong Chung, Stephen Hewitt, Steven Libutti

Cancer Res (2017) 77 (13_Supplement): 4718.

DOI: https://doi.org/10.1158/1538-7445.AM2017-4718

Published: 01 July 2017

View article

Journal Articles

Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF

Su Yeon Han, Aram Ko, Haruhisa Kitano, Chel Hun Choi, Min-Sik Lee, Jinho Seo, Junya Fukuoka, Soo-Youl Kim, Stephen M. Hewitt, Joon-Yong Chung, Jaewhan Song

Cancer Res (2017) 77 (2): 343–354.

DOI: https://doi.org/10.1158/0008-5472.CAN-16-0613

Published: 16 January 2017

View article

Includes: Supplementary data

Journal Articles

Abstract 3384: IGFBP5-derived peptide as a novel angiogenesis inhibitor for treatment of ovarian cancer

Jeong-Won Lee, Jae Ryoung Hwang, Young-Jae Cho, Yoo-Young Lee, Chel Hun Choi, Duk-Soo Bae, Byoung-Gie Kim

Cancer Res (2016) 76 (14_Supplement): 3384.

DOI: https://doi.org/10.1158/1538-7445.AM2016-3384

Published: 15 July 2016

View article

Journal Articles

Abstract 4618: Therapeutic targeting for sphingosine kinase 1 in epithelial ovarian cancer

Jeong-Won Lee, Ji Yoon Ryu, Hye-Kyung Jeon, Young-Ae Park, Young-Jae Cho, Jung-Joo Choi, Yoo-Young Lee, Tae-Joong Kim, Chel Hun Choi, Byoung-Gie Kim, Duk-Soo Bae

Cancer Res (2014) 74 (19_Supplement): 4618.

DOI: https://doi.org/10.1158/1538-7445.AM2014-4618

Published: 01 October 2014

View article

Journal Articles

Abstract 5561: Dual targeting of angiotensin receptors (AGTR1 and AGTR2) as a new therapeutic strategy in epithelial ovarian carcinoma.

Young Ae Park, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim, Ha-Jeong Kim, Chel Hun Choi

Cancer Res (2013) 73 (8_Supplement): 5561.

DOI: https://doi.org/10.1158/1538-7445.AM2013-5561

Published: 15 April 2013

View article

Journal Articles

Abstract 892: Angiotensin II /angiotensin II type I receptor (AGTR1) promotes cell growth in epithelial ovarian cancer

Jeong-Won Lee, Young-Ae Park, Chel Hun Choi, Yoo-Young Lee, Jung-Joo Choi, Byoung-Gie Kim, Duk-Soo Bae, Hye-Kyung Jeon, Ha-Jeong Kim, Young Jae Cho, Jee-Yun Ryu

Cancer Res (2012) 72 (8_Supplement): 892.

DOI: https://doi.org/10.1158/1538-7445.AM2012-892

Published: 15 April 2012

View article

Journal Articles

Abstract 2105: High Galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion

Jeong-Won Lee, Ha-Jeong Kim, Hye-Kyung Jeon, Young Jae Cho, Young Ae Park, Jung-Joo Choi, Yoo-Young Lee, Chel Hun Choi, Tae-Joong Kim, Duk-Soo Bae, Byoung-Gie Kim

Cancer Res (2012) 72 (8_Supplement): 2105.

DOI: https://doi.org/10.1158/1538-7445.AM2012-2105

Published: 15 April 2012

View article

Journal Articles

Abstract 301: 67-kDa laminin receptor as prognostic marker and therapeutic target in epithelial ovarian carcinoma

Jeong-Won Lee, Young-Jae Cho, Chel-Hun Choi, Young Ae Park, Jung-Joo Choi, Hye-Kyeong Jeon, Byoung-Gie Kim, Duk-Soo Bae

Cancer Res (2011) 71 (8_Supplement): 301.

DOI: https://doi.org/10.1158/1538-7445.AM2011-301

Published: 15 April 2011

View article

Journal Articles

Abstract 438: Hif-2α expression and radioresistance of cervical cancer

Min Kyu Kim, Tae Joong Kim, Chel Hun Choi, Jeong Won Lee, Je Ho Lee, Duk Soo Bae, Byoung Gie Kim

Cancer Res (2010) 70 (8_Supplement): 438.

DOI: https://doi.org/10.1158/1538-7445.AM10-438

Published: 15 April 2010

View article

Journal Articles

Abstract #564: MicroRNA profiles and potential capacities as biomarker in human endometrioid adenocarcinoma

Chel Hun Choi, Jung-Joo Choi, Young Ae Park, Tae-Joong Kim, Jeong-Won Lee, Chul Joong Kim, You-Young Lee, Byoung-Gie Kim, Je-Ho Lee, Duk-Soo Bae, Eun-Ju Lee

Cancer Res (2009) 69 (9_Supplement): 564.

Published: 01 May 2009

View article

Journal Articles

Increased expression of tissue transglutaminase (TG2) is associated with chemo-resistance in ovarian cancer cell lines

Chel Hun Choi, Byoung-Gie Kim, Woo Young Kim, Jung-Joo Choi, Young Ae Park, Tae-Joong Kim, Jeong-Won Lee, Heeseok Kang, Je-Ho Lee, Duk-Soo Bae

Cancer Res (2008) 68 (9_Supplement): 3222.

Published: 01 May 2008

View article

Journal Articles

High expression of tissue inhibitors of metalloproteinase-2 (TIMP-2) in serous ovarian carcinomas and its role in ovarian tumorigenesis

Byoung-Gie Kim, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Je-Ho Lee, Seung Bae Rho, Yoon-La Choi

Cancer Res (2006) 66 (8_Supplement): 1058.

Published: 15 April 2006

View article

NARROW

Abstract CT010: A phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer (KGOG 3046/TRU-D)

Abstract CT123: Phase I study of a B cell-based and monocyte-based immunotherapeutic vaccine, BVAC-C, in human papillomavirus type 16- or 18-positive recurrent cervical cancer

Correction: Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF

Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3–NANOG Axis

HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells

Abstract 4718: Filamin A interacting protein 1-like is a marker of prognosis, progression and chemosensitivity in ovarian cancer

Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF

Abstract 3384: IGFBP5-derived peptide as a novel angiogenesis inhibitor for treatment of ovarian cancer

Abstract 4618: Therapeutic targeting for sphingosine kinase 1 in epithelial ovarian cancer

Abstract 5561: Dual targeting of angiotensin receptors (AGTR1 and AGTR2) as a new therapeutic strategy in epithelial ovarian carcinoma.

Abstract 892: Angiotensin II /angiotensin II type I receptor (AGTR1) promotes cell growth in epithelial ovarian cancer

Abstract 2105: High Galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion

Abstract 301: 67-kDa laminin receptor as prognostic marker and therapeutic target in epithelial ovarian carcinoma

Abstract 438: Hif-2α expression and radioresistance of cervical cancer

Abstract #564: MicroRNA profiles and potential capacities as biomarker in human endometrioid adenocarcinoma

Increased expression of tissue transglutaminase (TG2) is associated with chemo-resistance in ovarian cancer cell lines

High expression of tissue inhibitors of metalloproteinase-2 (TIMP-2) in serous ovarian carcinomas and its role in ovarian tumorigenesis

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only